Skip to main content

Security report for ibsa.hu

IBSA Pharma Kft. · Healthcare · Hungary

Medium risk. 5 critical or high findings in GDPR outside view, Security headers and 1 other check.

Security score

67/100

Risk levelMedium

0–100, higher is better. How it is calculated

IBSA Pharma Kft. is a Hungarian subsidiary of the Swiss multinational pharmaceutical group IBSA, founded in 1945. The company operates in over 90 countries with 20 subsidiaries worldwide, focusing on pharmaceutical manufacturing and therapeutic areas such as reproductive medicine, endocrinology, and dermatology. The website reflects a mature digital presence with multilingual support and comprehensive corporate information. The technical infrastructure leverages modern JavaScript libraries, Bootstrap framework, and is hosted behind Incapsula security services, ensuring good performance and protection. Security posture is strong with HTTPS enforcement, security headers, and cookie consent mechanisms aligned with GDPR requirements. However, explicit security policies and incident response information are not publicly available, representing an area for improvement. Overall, the website is professional, trustworthy, and compliant with privacy regulations, serving its target audience effectively.

Scanned

NIS2 and GDPR posture

GDPR outside view
40/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

5 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      Third-party services without privacy policy

      Detected services: Google Analytics, Google APIs

      What to do: Document all third-party data sharing in your privacy policy

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching ibsa.hu

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
45
Email security
70
DNS health
75
Network security
100
GDPR outside view
40
Average
67

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention ibsa.hu, from OffSeq Breach.

No leaked records found

Breach holds no records for ibsa.hu right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company holds a strong market position as a multinational pharmaceutical entity with a broad geographic footprint and diversified therapeutic focus. Its business model centers on manufacturing and distributing pharmaceutical products through subsidiaries and partners. The website's linkage to multiple country-specific domains and partner organizations indicates a well-established partnership ecosystem. The availability of corporate brochures and sustainability reports signals transparency and commitment to ESG principles. Growth indicators include a large employee base and extensive market reach. The company targets healthcare professionals and consumers in Hungary and internationally, leveraging digital channels for corporate communication and compliance.

Security posture

The website demonstrates a mature security posture with enforced HTTPS, presence of key security headers, and integration of a cookie consent mechanism via OneTrust. Hosting behind Incapsula provides additional DDoS and web application firewall protections. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, the absence of publicly available security policies, incident response contacts, or vulnerability disclosure mechanisms suggests limited transparency in security governance. The site would benefit from publishing these documents and providing clear security contact channels to enhance trust and compliance.

Recommendations

  1. Publish a dedicated security policy and incident response plan accessible on the website.
  2. Implement and publish a vulnerability disclosure policy or security.txt file to encourage responsible reporting.
  3. Enhance accessibility features to improve compliance with WCAG standards.
  4. Regularly review and update third-party scripts to mitigate potential vulnerabilities.
  5. Provide public contact information for the Data Protection Officer or security team to improve transparency.

Contact details published on the site

Addresses
Legal name
IBSA Pharma Kft.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
IBSA Pharma Kft.
Description
Az IBSA Cégcsoport egy svájci multinacionális gyógyszeripari vállalat, melynek székhelye Svájcban, Luganoban található.
Key services
Pharmaceutical product manufacturing, Therapeutic area specialization, Sustainability initiatives
Content quality
good
Branding
consistent

Technology

Stack
jQuery 3.7.1, Bootstrap, Google Tag Manager, Google Analytics, Swiper.js, LazySizes, Select2
Frameworks
Bootstrap
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent banner implemented
  • No exposed sensitive data in HTML
  • Use of security headers

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. Comprehensive cookie consent mechanism implemented with OneTrust.
  3. Clear corporate identity and multinational presence.
  4. Multiple external links to subsidiaries and partner sites with user warnings.
  5. No visible security or privacy policy documents beyond GDPR cookie and privacy policies.
  6. No explicit terms of service or incident response policies found.
  7. Use of modern JavaScript libraries and frameworks.
  8. Hosting via Incapsula providing security and DDoS protection.
  9. No suspicious or malicious content detected.
  10. Contact information is clear and includes phone and physical address.
Technical notes

Notes

The website uses a modern technology stack including jQuery 3.7.1, Bootstrap for responsive design, Swiper.js for sliders, and Select2 for enhanced select elements. Google Tag Manager and Google Analytics are used for tracking and analytics. The site is hosted behind Imperva Incapsula, providing security and performance benefits. Performance is moderate with lazy loading images and asynchronous script loading. SEO is supported by proper meta tags and Open Graph data. The CMS is not explicitly identified, suggesting a custom or proprietary solution. Technical risks are minimal but could be further reduced by continuous monitoring of third-party dependencies and improving accessibility compliance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with ibsa.hu. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review ibsa.hu.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.